--Roche Holding is losing money in Russia because medicine prices are set in rubles, Chief Executive Severin Schwan tells Swiss newspaper Tages-Anzeiger in an interview.

--The CEO said the company has a responsibility to the patients who are depending on its medicines, and that it has 800 workers in Russia, though no production sites, the newspaper reports.

--Roche said in a statement that about 1% of group sales are generated in Russia.

Full story in German: https://bit.ly/35j0WLx

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

March 29, 2022 06:45 ET (10:45 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to May 2024 Click Here for more Roche (QX) Charts.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Roche (QX) Charts.